That's really stupid. If there was a CRL, it would be in Jan. The only time they reply early is positive. The drop was expected, as soon as the announcement was released.
The sea of red, not so much.
(Myself), people who understood the six month review, knew, or expected a sell off. In fact, it should be in writing, somewhere. One of these threads. Two month review was on the cards.
But in saying that, people seem to forget, HLHS is still on this quarter. I'm only holding what I had for the original CRL. And I'm happy with that. Cards are falling my way for once.
HODL
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-240
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |